Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD200/OX2 Antibody (OX-102), DyLight 350, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NB10065603UV

Catalog No. NB165603UV


Only null left
Add to Cart

Description

Description

CD200/OX2 Monoclonal specifically detects CD200/OX2 in Rat samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Frozen.
Specifications

Specifications

CD200/OX2
Monoclonal
DyLight 350
50mM Sodium Borate with 0.05% Sodium Azide
CD200
Membrane fraction of thioglycollate-elicited rat peripheral cells.
0.125 mL
Immunology
4345
Rat
Purified
Western Blot, Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Frozen)
OX-102
Western Blot, Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Frozen
antigen identified by monoclonal MRC OX-2, CD200 antigenMOX1, CD200 molecule, MOX2MRC, MRC OX-2 antigen, OX-2, OX-2 membrane glycoprotein
Mouse
Protein G purified
RUO
Primary
NB100-65603 recognizes the rat OX2 (CD200) receptor 1. This antigen is a heavily glycosylated 60-100kD cell surface molecule expressed by cells of the myeloid lineage but not by T or B lymphocytes. This antibody has been shown to block the interaction of OX2 receptor 1 with CD200.
Store at 4C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.